ロード中...
Rho kinase inhibitors for treatment of glaucoma
Affecting 60 million patients, glaucoma is the second leading cause of blindness worldwide. Despite the availability of multiple medical and surgical treatments with effective intraocular pressure lowering, many patients still progress to become visually handicapped from glaucoma due to therapeutic...
保存先:
| 出版年: | Expert Rev Ophthalmol |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6319899/ https://ncbi.nlm.nih.gov/pubmed/30613208 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1586/eop.11.65 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|